J Cancer 2014; 5(4):291-300. doi:10.7150/jca.8017 This issue


Future Directions for the Early Detection of Recurrent Breast Cancer

Erika J. Schneble1✉, Lindsey J. Graham1, Matthew P. Shupe1, Frederick L. Flynt1, Kevin P. Banks1, Aaron D. Kirkpatrick1, Aviram Nissan2, Leonard Henry3, Alexander Stojadinovic4, Nathan M. Shumway1, Itzhak Avital4, George E. Peoples1, Robert F. Setlik1

1. San Antonio Military Medical Center (SAMMC), 3551 Roger Brooke Dr., Ft. Sam Houston, TX 78234, USA.
2. Hadassah Medical Center, Kiryat Hadassah, POB 12000, Jerusalem, 91120, Israel.
3. IU Health Goshen, 200 High Park Ave., Goshen, IN 46526, USA.
4. Bon Secours Cancer Institute, 5855 Bremo Road, Richmond, VA 23226, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF. Future Directions for the Early Detection of Recurrent Breast Cancer. J Cancer 2014; 5(4):291-300. doi:10.7150/jca.8017. Available from https://www.jcancer.org/v05p0291.htm

File import instruction


The main goal of follow-up care after breast cancer treatment is the early detection of disease recurrence. In this review, we emphasize the multidisciplinary approach to this continuity of care from surgery, medical oncology, and radiology. Challenges within each setting are briefly addressed as a means of discussion for the future directions of an effective and efficient surveillance plan of post-treatment breast cancer care.

Keywords: Breast cancer, recurrence, adjuvant, surveillance, follow-up.